The W.H.O. announced on Feb. 11 a new name for the disease caused by the current novel coronavirus epidemic: Coronavirus Disease 2019 (COVID-19). As for the virus itself, the International Committee on Taxonomy of Viruses has decided on SARS-CoV-2, which “formally recognizes this virus as a sister to severe acute respiratory syndrome coronaviruses.” #COVID19 and #SARSCoV2 are the common social media signatures we are encouraging people use.

The information on this page is not intended as medical advice or clinician guidance. Please help us be more inclusive of fact-based resources that would add to the quality of this page by sending to: editor@globalbiodefense.com

FEATURED ARTICLES

Abbott Receives EUA for Rapid Point-of-Care COVID-19 Diagnostic

Abbott Receives EUA for Rapid Point-of-Care COVID-19 Diagnostic

Abbott today announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the fastest available molecular point-of-care test…

DoD Looks to Panther Fusion System for High-Throughput Coronavirus Diagnostics

DoD Looks to Panther Fusion System for High-Throughput Coronavirus Diagnostics

The U.S. Army Medical Research Acquisition Activity (USAMRAA) announced a contract action to Hologic, Inc. this month to acquire the Panther Fusion open access platform…

University of Washington Releases Predictive Model for Hospital Utilization and Deaths Due to COVID-19

University of Washington Releases Predictive Model for Hospital Utilization and Deaths Due to COVID-19

Modeling scientists from the University of Washington Institute for Health Metrics and Evaluation (IHME) have presented their first set of estimates of daily health service…

NIAID Issues Notice of Special Interest for SARS-CoV-2 and COVID-19 Research

NIAID Issues Notice of Special Interest for SARS-CoV-2 and COVID-19 Research

The National Institute of Allergy and Infectious Diseases today issued a Notice of Special Interest (NOSI) to highlight the need for research on Severe Acute…

5 Questions Answered About Chloroquine: An Unproven Drug Against Coronavirus

5 Questions Answered About Chloroquine: An Unproven Drug Against Coronavirus

An Arizona man died, and his wife was hospitalized, after taking a form of chloroquine, which President Trump has touted as an effective treatment for…

The Role of the Science Advisory Group for Emergencies (SAGE) in Pandemic Response

The Role of the Science Advisory Group for Emergencies (SAGE) in Pandemic Response

COVID-19 has brought a lot of new people to the attention of the public. Unlike politicians, these “chief” advisers who are mainly scientists and medics,…

View All Featured News


RESOURCES | LINKS


HEADLINE NEWS

Nothing found.

View All Headline News


RESEARCH HIGHLIGHTS

Persons Evaluated for 2019 Novel Coronavirus — United States, January 2020

CDC Morbidity and Mortality Weekly Report (MMWR) On January 17, CDC and the U.S. Department of Homeland Security’s Customs and Border Protection began health screenings at U.S.…

Bats’ Fierce Immune Systems Drive Viruses To Higher Virulence, Making Them Deadlier in Humans

A new University of California, Berkeley, study finds that bats’ fierce immune response to viruses could drive viruses to replicate faster, so that when they jump to…

Steroids Could Do More Harm Than Good in Treating Coronavirus

Steroids should be avoided in the treatment of the current novel coronavirus, experts have advised. A commentary article published in The Lancet concludes that, based on evidence from previous…

A Pneumonia Outbreak Associated with a New Coronavirus of Probable Bat Origin

NOTE: The following paper (.pdf) is undergoing accelerated peer-review. Abstract follows: Since the SARS outbreak 18 years ago, a large number of severe acute respiratory syndrome-related coronaviruses…

Coronavirus and Brexit: UK Must Act Quickly Before Being Shut out of Europe’s Health Protection System

The threat posed by 2019-nCoV and the fragmentation of existing health protection systems caused by Brexit call for urgent assessment of cross Europe cooperation, say Mark Flear…

View All Research Journal Highlights

JOURNAL HUBS

“We call on researchers, journals and funders to ensure that research findings and data relevant to this outbreak are shared rapidly and openly to inform the public health response and help save lives.” – Wellcome Trust

NEJM Novel Coronavirus

JAMA Network 2019-nCoV

The Lancet 2019-nCoV Resource Center

Springer Nature Novel Coronavirus Articles

The BMJ Coronavirus Free Online Resources

Elsevier Novel Coronavirus Information Center

BioRxiv Preprint Server *(Caution: information not yet peer-reviewed)

ASM Journal Network Coronavirus Articles American Society for Microbiology

RSTMH Coronavirus Collection


FUNDING | CONTRACTS | GRANTS


Sign up to receive weekly insights from Global Biodefense


INDUSTRY NEWSWIRE

Inovio, Beijing Advaccine Collaborate to Advance INO-4800 Vaccine

Inovio Pharmaceuticals, Inc. today announced that it is collaborating with Beijing Advaccine Biotechnology Co. to advance the development in China of INO-4800, Inovio’s vaccine against the recently…

AbCellera is Mobilizing a Response to the Novel Coronavirus Outbreak as Part of its DARPA P3 Program

AbCellera confirms that it is mobilizing its pandemic response platform against the ongoing outbreak of a novel coronavirus (2019-nCoV) originating in Wuhan, China. Since 2018, under the…

UNICEF Ships 6 Metric Tons of Supplies to Support China’s Response to Novel Coronavirus Outbreak

On 28 January 2020 in Copenhagen, Denmark, protective equipment is loaded on a truck at UNICEF’s global supply hub in Copenhagen to go to the airport where…

Bill & Melinda Gates Foundation Commits $10 Million to Global Response to 2019-nCoV

The Bill & Melinda Gates Foundation today announced that it is immediately committing $10 million in emergency funds and corresponding technical support to help frontline responders in…

Sirnaomics Advances RNAi-Based Prophylactics and Therapeutics to Battle SARI Caused by 2019-nCoV

Sirnaomics Inc., a leading biopharmaceutical company in discovery and development of novel RNAi therapeutics, announced today that it has mobilized its research teams both in USA and…

View All Industry Newswires


STATE RESOURCES

Arkansas

Arkansas Department of Health

Arkansas Public Health Laboratory

Kentucky

Kentucky Division of Laboratory Service

State Health Officials Actively Monitoring for 2019 Novel Coronavirus 1/29 DPH

District of Columbia
American Samoa